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Background: Weaning from mechanical ventilation is difficult in the intensive care unit (ICU). Many controversial questions remain un-
answered concerning the predictors of weaning failure. This study investigates patient characteristics and delayed weaning after lung 
transplantation.
Methods: This study retrospectively reviewed the medical records of 17 lung transplantation patients from October 2012 to December 
2013. Patients able to be weaned from mechanical ventilation within 8 days after surgery were assigned to an early group (n = 9), and 
the rest of the patients were assigned to the delayed group (n=8). Patients’ intraoperative and postoperative characteristics were col-
lected and analyzed, and conventional weaning predictors, including rapid shallow breathing index (RSBI), were also assessed.
Results: The results of the early group showed a significantly shorter ICU stay in addition to a shorter hospitalization overall. Notably, 
the early group had a higher body mass index (BMI) than the delayed group (20.7 vs. 16.9, p = 0.004). In addition, reopening occurred 
more frequently in the delayed group (1/9 vs. 5/8, p = 0.05). During spontaneous breathing trials, tidal volume (TV) and arterial oxygen 
tension were significantly higher in the early group compared to the delayed weaning group, but differences in RSBI and respiratory 
rate (RR) between groups were not statistically significant.
Conclusions: Low BMI might be associated with delayed ventilator weaning in lung transplantation patients. In addition, instead of the 
traditional weaning predictors of RSBI and RR, TV might be a better predictor for ventilator weaning after lung transplantation.
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Introduction
Lung transplantation is one of the few feasible treatment op-
tions for end-stage lung disease. The first lung transplantation 
was described in 1963,[1] and it provided decades of survival 
after decades.[2] Since the first successful case, the number of 
transplants has continued to increase and the clinical outcomes 
of lung transplantation continue to improve, as the International 
Society of Heart and Lung Transplantation reported over 43,000 
transplants worldwide, and the associated 5-year survival rate 
reached 53%.[3] Specifically, in Korea, the first lung trans-
plantation was reported in 1996, and a case series of 13 patients 
was published in 2006.[4]
Following transplantation, the day of extubation is one of the 
most critical moments in the intensive care unit (ICU) stay. 
Early extubation after lung transplantation (within 12 hours) has 
been frequently reported,[5,6] but this maneuver should be per-
formed very cautiously in select patients to avoid the serious 
complications associated with reintubation. The median time to 
extubation in lung transplantation patients was reported to be 
approximately 3 days, and the range was between one and 312 
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hours.[7,8] According to these reports, most lung transplantation 
patients undergo mechanical ventilator weaning and extubation 
while still in the ICU.
When deciding to wean patients from mechanical ventilation 
(MV), many parameters are considered, including demographic 
data, perioperative variables and laboratory data such as accept-
able gas exchange. MV itself is a major determinant of ICU 
length of stay (LOS). One prospective study specific to lung sur-
gery reported that preoperative body mass index (BMI) prior to 
lung volume reduction surgery is a sensitive measure of the pa-
tient’s nutritional state, and a low BMI correlates to prolonged 
postoperative MV.[9] In addition to BMI, Lee et al.[10] also 
published that the median ICU LOS following a single lung 
transplantation was 5 days, and that pulmonary hypertension 
and poor immediate postoperative oxygenation (ratio of the par-
tial pressure of arterial oxygen to the fraction of inspired oxygen 
[PaO2/FiO2] of less than 200 mmHg) were good predictors of a 
prolonged ICU stay.[10] 
Extubation and weaning from MV performed in a timely 
manner are critical to ICU management to reduce ICU LOS. To 
identify risk factors for prolonged MV after unilateral or bi-
lateral lung transplantation, we retrospectively reviewed the 
medical records of lung transplantation patients who were 
weaned from MV. We classified and analyzed clinical data that 
may impact the ability to wean a patient from MV, and or-
ganized this data by the preoperative, intraoperative and post-
operative periods. Lung mechanics and arterial blood gas analy-
sis (ABGA) during spontaneous breathing trials (SBTs) were in-
vestigated, in addition to the well-known weaning predictors of 
tidal volume (TV), respiratory rate (RR), and rapid shallow 
breathing index (RSBI).[11-13] 
Materials and Methods
This retrospective study was approved by the Institutional 
Review Board (IRB) of Severance Hospital (Ref: 4-2013-0927), 
and the need for informed consent was waived by the IRB. 
Seventeen patients aged 18 years or older who were admitted to 
the ICU from October 2012 after unilateral or bilateral lung 
transplantation were enrolled. Exclusion criteria included early 
death within the immediate postoperative ICU stay and pro-
longed MV (> 3 months). Data were collected retrospectively by 
reviewing electronic medical records, and the same surgeon per-
formed all surgeries. 
Demographic data and intraoperative and postoperative vari-
ables that may impact the ability to wean a patient from MV 
were investigated. Demographic data included age, gender, 
height, weight, BMI, and comorbid illness. Preoperative pulmo-
nary function testing, echocardiography and 6-minute walking 
distance were also collected. Intraoperative variables included 
operation time, fluid intake, urine output, blood transfusion his-
tory, estimated blood loss, and salvaged blood from the Cell 
Saver (Cell Saver 5 System, Haemonetics, Braintree, MA, USA). 
ABGA, TV, and RR throughout the SBTs were recorded. RSBI 
was calculated from TV and RR.
Unless a contraindication to the SBT was present, such as 
acute rejection or severe bleeding, a spontaneous awakening tri-
al (SAT) and SBT were initiated and evaluated by the multi-
disciplinary team, which included the surgeon, pulmonologists, 
anesthesiologists, pharmacists, and nurses. According to some 
studies, no difference in the percentage of patients passing the 
SBT or the percentage of patients successfully extubated between 
T-tube trial and low levels of pressure support (PS),[14,15] low 
levels of PS less than 10 cmH2O and T-tube trial were used as 
SBT in this study. In addition, ABGA was performed 60 mi-
nutes after the SBT. If the respiratory pattern, gas exchange, he-
modynamic stability and subject comfort were sufficient to pass 
the SBT, extubation for endotracheally intubated patients or 
weaning from MV for patients with tracheostomies were done. 
If there was any controversy about the SBT results, the SBT was 
extended to 120 minutes. After a maximum duration of 120 mi-
nutes, the multidisciplinary critical care team decided whether 
to extubate or wean. When patients failed an initial SBT, the 
team reviewed possible reversible etiologies for failure, such as 
respiratory load (increased work of breathing, reduced com-
pliance due to pneumonia or edema, airway difficulty), cardiac 
dysfunction, neuromuscular dysfunction, neuropsychological 
complications, metabolic disturbance, inappropriate nutrition 
and anemia. After correcting these etiologies, SBTs were re-
peated daily in order to successfully extubate the patient at the 
earliest possible time.
Notably, SBTs were immediately aborted in the following sit-
uations: 1. Clinical assessment and subjective indices suggest-
ing agitation, anxiety, depressed mental status, perspiration, 
cyanosis, increased accessory muscle activity and dyspnea, 2. 
Objective measurements showing a PaO2 < 60 mmHg on FiO2 ≥ 
0.5 or a percutaneous oxygen saturation (SpO2) ≤ 88%, arterial 
carbon dioxide partial pressures (PaCO2) > 65 mmHg, RR > 45 
breaths/min, RSBI > 105 breaths/min/L, heart rate (HR) over 
140 beats/min or sustained increase or decrease of > 20%, sys-
tolic blood pressure (SBP) > 180 mmHg or SBP < 90 mmHg, 
and 3. Measurements showing newly developed or aggravated 
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Table 1. Characteristics of patients with early and delayed weaning after lung transplantation
Overall Early group (n = 9) Delayed group (n = 8) p value
Age, yr     52 (42-58)      55 (50-65)      48 (35-53) 0.04
Sex, M     12 (70.6)       7 (77.8)        5 (62.5) 0.62
BMI, kg/m² 19.38 (16.92-20.81) 20.72 (19.13-21.94) 16.92 (13.50-19.25) < 0.01
BSA, m²  1.55 (1.44-1.70)   1.69 (1.55-1.73)   1.49 (1.36-1.55) 0.02
KONOS registration to op., d     75 (8-256)      75 (13-295)    102 (6-211) 0.92
MV duration, d     8.0 (3.3-21.7)     3.7 (2.4-5.9)   21.7 (13.1-40.4) < 0.01
Hospital stay, d   42.0 (27.8-71.8)   28.5 (22.5-46.3)   75.0 (43.5-122.8) 0.01
ICU stay, d   13.0 (5.5-28.5)     6.0 (5.0-8.0)   24.5 (16.0-41.8) < 0.01
Re-open        6 (35.3)       1 (11.1)        5 (62.5) 0.05
Mortality        3 (17.6)       3 (33.3)        0 (0) 0.21
Comorbid illness
CRF        1 (5.9)        0 (0)        1 (12.5) 0.47
Pneumonia        5 (29.4)        3 (33.3)        2 (25.0) 1.00
Long-term steroid use      11 (64.7)        6 (66.7)        5 (62.5) 0.63
Smoking   20.0 (0-30.0)   25.0 (0-32.0)     7.5 (0-28.8) 0.42
Ventilator use       6 (35.3)        3 (33.3)        3 (37.5) 0.63
ECMO use       1 (5.9)       1 (11.1)        0 (0) 1.00
Preoperative evaluation
Six-minute walk test   195 (105-313)    280 (75-320)    140 (122-270) 0.81
FEV1 (%)     31 (21-47)      31 (23-44)      35 (18.6-41) 0.91
FVC (%)     40 (26-55)      37 (28-63)      42 (53-19) 0.95
EF (%, Echo)     65 (58-69)      65 (53-70)      63 (60-67) 0.96
RVSP*, mmHg     45 (38-60)      50 (43-71)      42 (32-55) 0.25
Donor information
Donor age, yr     40 (26-44)      40 (28-44)      40 (22-49) 0.81
Ischemic time, min   247 (176-341)    247 (229-327)    247 (147-382) 0.70
*RVSP was measured by echocardiography or right-sided catheterization. BMI: Body Mass Index (kg/m²); BSA: Body Surface Area (m²); KONOS: 
Korean Network for Organ Sharing; MV: mechanical ventilation; ICU: intensive care unit; CRF: Chronic renal failure; ECMO: extracorporeal mem-
brane oxygenation; FEV1: forced expiratory volume in 1 second; FVC: forced vital capacity; EF: ejection fraction (%); RVSP:  right ventricular systolic 
pressure.
cardiac arrhythmia. 
Once the median duration of MV was identified, the patients 
were divided into two groups, either the early or delayed group, 
based on median duration of MV.
Statistical analysis
Data were presented as the median (interquartile range) or the 
number (percentage) of patients. Data analysis was performed 
using the Statistical Package for the Social Sciences (SPSS, 
Version 18; SPSS Inc., Chicago, IL, USA). Comparisons be-
tween the two groups were analyzed using the Mann-Whitney 
test for continuous data and using the χ2 test or Fisher’s exact 
test for categorical data. A p-value less than 0.05 was considered 
statistically significant. 
Results
A total of 17 patients were enrolled in this study (Table 1). 
The median patient age was 52 years. Hospital death occurred in 
three patients. Etiologies of end-stage lung disease included idi-
opathic pulmonary fibrosis (9 patients), complications from 
bone marrow transplantation (3 patients), bronchiectasis (1 pa-
tient), usual interstitial pneumonia (1 patient), lymphangioleio-
myomatosis (1 patient), dermtatomyositis (1 patient) and chron-
ic obstructive pulmonary disease (COPD) (1 patient).
In this study, the median duration of MV was 8.0 days. 
Brochard [16] proposed that patients who are difficult to wean 
often require up to three SBTs or may take as long as 7 days 
from the first SBT to achieve successful weaning. In our study, 
unless there was a contraindication to the SBT, such as acute re-
jection or severe bleeding, the first SBT was usually initiated the 
day after surgery. Therefore, patients requiring up to 7 days 
from the first failed SBT (post-op day 8) to achieve successful 
weaning were assigned to the delayed group. Thus, the early and 
delayed groups were defined by a MV duration of 8 days. Nine 
patients were classified into the early group and eight patients 
were classified into the delayed group. The first SBT failure rate 
was similar between the two groups (2/9 vs. 3/8, p = 0.62).
In the early group, patients were older (55 vs. 48 years, p = 
0.04) and had less frequent reoperation rates (1/9 vs. 5/8, p = 
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Table 2. Intraoperative variables of patients with early and delayed weaning after lung transplantation
Overall Early group (n = 9) Delayed group (n = 8) p value
Operation time, h  6.85 (6.05-8.15) 6.85 (5.43-7.40)  7.60 (6.52-9.58) 0.18
Unilateral/Bilateral 3/14 2/7 1/7 0.55
Total fluid intake, ml 8420 (5950-10400) 7820 (5250-9225) 9275 (6838-15850) 0.29
Colloid, ml 1000 (500-1500) 1000 (500-1250) 1250 (1000-1500) 0.19
pRBC, units       7 (3-13)       6 (3-9)       4 (3-16) 0.36
FFP, units       3 (1-5)       3 (2-5)       4 (1-9) 0.66
Plt conc, units     11 (6-12)       6 (3-12)     12 (6-12) 0.27
Cell saver, ml   865 (488-2583)   700 (450-1210) 2530 (500-4140) 0.14
Urine output, ml 2270 (1295-3708) 2050 (1360-3708) 2385 (1218-5145) 1.00
Blood loss, ml 2500 (2050-4500) 2500 (1925-4035) 5075 (2000-9500) 0.30
ECMO time, min   309 (256-388)   278 (231-333)   337 (282-460) 0.12
pRBC: packed red blood cells;  FFP: fresh frozen plasma;  Plt conc: platelet concentrate; ECMO: extracorporeal membrane oxygenation.
Table 3. Postoperative variables of patients with early and delayed weaning after lung transplantation
Overall Early group (n = 9) Delayed group (n = 8) p value
ECMO use (%) 8 (47.1) 1 (11.1) 7 (87.5) < 0.01
ECMO duration, d 3 (1-9) 1 3 (1-11) 0.26
VAP (%) 7 (41.2) 1 (11.1) 6 (75.0) 0.02
Bleeding > 1000 ml/d 5 (29.4) 1 (11.1) 4 (50.0) 0.13
Arrhythmia (%) 3 (17.6) 1 (11.1) 2 (25.0) 0.58
AKI (%) 2 (11.8) 0 (0) 2 (25.0) 0.21
CRRT (%) 1 (5.9) 0 (0) 1 (12.5) 0.47
Sepsis (%) 2 (11.8) 0 (0) 2 (25.0) 0.21
Re-intubation (%) 2 (11.8) 0 (0) 2 (25.0) 0.21
ECMO: extracorporeal membrane oxygenation; VAP: ventilator associated pneumonia; AKI: acute kidney injury; CRRT: continuous renal replacement 
therapy.
Table 4. Parameters associated with the success of the first spontaneous breathing trial
Overall Early group (n = 9) Delayed group (n = 8) p value
Respiratory parameters before SBT
TV, mL    406 (357-434)    418 (386-467)   361 (345-408) 0.043
RR (breaths/min)      16 (14-23)      16 (14-19)     23 (15-24) 0.097
RSBI (breaths/min/L)   41.7 (34.7-63.0)   36.6 (31.4-44.1)  59.5 (40.7-66.0) 0.083
Ineffective cough      12 (70.6)        6 (66.7)       6 (75.0) 1.0
Sputum > moderate      14 (82.4)        6 (66.7)       8 (100) 0.21
ABG before SBT
pH   7.46 (7.43-7.48)   7.46 (7.44-7.47)   7.45 (7.40-7.50) 0.81
PaO2 134.6 (115.0-151.7) 145.4 (131.4-162.5) 122.8 (93.7-134.6) 0.016
PaCO2   38.3 (31.6-42.6)   41.0 (30.8-45.0)   36.8 (31.6-41.3) 0.56
PaO2/FiO2    337 (291-434)    415 (306-449)    327 (251-363) 0.10
ABG one hour after SBT
PaO2 118.6 (98.7-147.3) 134.4 (111.0-155.1)   93.6 (80.4-129.3) 0.045
PaCO2   36.9 (31.3-47.1)   36.9 (29.1-48.4)   37.2 (34.2-46.4) 0.72
PaO2 decrease (%)   13.2 (3.5-17.5)   13.2 (3.1-15.7)   13.5 (-3.4-19.8) 0.64
PaCO2 decrease (%)     6.9 (-15.3-9.5)     9.0 (-14.0-15.0)   -0.1 (-28.0-10.1) 0.29
Weaning results
First SBT-successful extubation, h   10.2 (1.9-61.1)     3.6 (1.9-21.8)    47.9 (3.9-171.9) 0.18
First SBT failure (%)        5 (29.4)        2 (22.2)         3 (37.5) 0.62
MV duration, d     8.0 (3.3-21.7)     3.7 (2.4-5.9)    21.7 (13.1-40.4) 0.001
SBT: spontaneous breathing trial; TV: tidal volume; RR: respiratory frequency; RSBI: rapid shallow breathing index (respiratory frequency to tidal vol-
ume ratio); ABG: arterial blood gas; PaO2: arterial oxygen tension; PaCO2: arterial carbon dioxide tension; MV: mechanical ventilation.
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0.05) than the delayed group (Table 1). Predictably, the ICU and 
hospital LOS were longer in the delayed group. Also, BMI (20.7 
vs. 16.9 kg/m2, p < 0.01) and BSA (1.7 vs. 1.4 m2, p = 0.02) were 
significantly higher in the early group.
Analysis of intraoperative and postoperative variables 
showed no significant differences between the groups, except 
for more frequent extracorporeal membrane oxygenation 
(ECMO) use and ventilator-associated pneumonia (VAP) in the 
delayed group (Table 2 and 3). ECMO was used when the im-
mediate postoperative lung function was insufficient to ad-
equately oxygenate the entire body. VAP, acute rejection and the 
general preoperative condition of the patient could affect post-
operative lung function.
In the early group, the TV just before the SBT was sig-
nificantly greater (418 vs. 361 ml, p = 0.04) compared to the de-
layed group, while respiratory rate and RSBI were not sig-
nificantly different between groups (Table 4). PaO2 measure-
ments prior to SBT and 1 hour after SBT were significantly 
higher in the early group than the delayed group, but PaO2/FiO2 
before SBT was not significantly different. However, patients 
were given different proportions of oxygen and were given oxy-
gen via different methods after SBT. Therefore, a higher PaO2 
before SBT and 1 hour after SBT in the early group does not al-
low for conclusions to be drawn.
Discussion
The results of the present study show that a low BMI is asso-
ciated with prolonged MV after lung transplantation. In addi-
tion, larger tidal volumes before the SBT are associated with a 
shorter MV duration in this patient population, while the con-
ventional weaning indicator, RSBI, did not predict early wean-
ing from MV. 
BMI and skeletal muscle mass have been reported to be good 
indicators of clinical outcomes in critically ill patients. In crit-
ically ill patients, the obesity-mortality paradox is a well-known 
phenomenon among the intensivists. In an observational study of 
approximately 154,000 ICU patients, BMIs less than 18.5 kg/m2 
demonstrated the highest mortality risk, while obese patients 
with BMIs ranging between 30 and 39.9 kg/m2 showed the low-
est risk of death (odds ratio of 0.86, 95% confidence interval 
0.83-0.90).[17] In addition, Gupta et al.[18] showed that low 
BMIs less than 18.5 kg/m2 were associated with increased mor-
tality in 793 surgical ICU patients. Similarly, sarcopenia, based 
on muscle cross-sectional area at the third lumbar vertebra, was 
associated with fewer ventilator-free and ICU-free days in eld-
erly patients.[19] An additional retrospective investigation re-
vealed that low BMI was associated with a higher risk of death 
in acute lung injury patients on MV[20], and a similar associa-
tion between low BMI less than 21 and delayed weaning from MV in 
chronic obstructive lung disease patients has been demonstrated.[21] 
De la Torre et al.[22] reported that there was no correlation be-
tween low BMI and delayed weaning in patients after lung 
transplantation. However, their study defined low BMI to be 
less than 20 kg/m2, not 18.5 kg/m2, which may have blunted 
their effects. Because in the other study, the Toronto Lung 
Transplant Group revealed that lower BMI less than 17 was as-
sociated with higher risk of 90-day mortality in the patient un-
dergoing lung transplantation.[23] 
Initially, BMI measurements were introduced to be a marker 
of the overall nutrition status of the human body. Because ad-
equate nutrition support can improve respiratory muscle con-
tractility and the subsequent ability to expectorate sputum, the 
duration of MV in critically ill patients could be prolonged in 
malnourished patients. Therefore, BMI is an important refer-
ence index that can be used to estimate MV duration and predict 
weaning from MV for post-transplantation patients, as the re-
sults of this study have indicated.
MV weaning covers the entire process of liberating the pa-
tients from mechanical support and from the endotracheal tube. 
Weaning from MV starts with a clinical picture suggesting that 
the patient could tolerate spontaneous breathing. Then, an as-
sessment of readiness to wean, a SBT, and extubation are carried 
out.[24] Previous studies have reported that the weaning failure 
rate after a single SBT is between 26 and 42%.[25,26]
If weaning is delayed, patients are exposed to unnecessary 
discomfort and the risk of complications, including stress ulcer, 
deep vein thrombosis or pulmonary embolism, and VAP, are 
increased. For these patients, the increased cost of care due to 
prolonged hospital and ICU stays can be devastating. The in-
cidence of unplanned extubation ranges from 0.3 to 16%,[27] 
and almost half of patients who underwent unplanned extubation 
during the weaning period did not require reintubation.[28] 
These findings suggest that a significant number of critically ill 
patients are enduring unnecessary lengths of MV and intubation. 
Esteban et al.[29] demonstrated that mortality increases with in-
creasing duration of MV, in part because of the complications of 
prolonged MV like VAP and airway trauma.[30] Coplin et 
al.[31] reported that mortality of brain-injured patients was 12% 
if there was no delay in extubation, but mortality was increased 
to 27% in cases of delayed extubation. Moreover, MV has been 
consistently associated with an increased cost of care of up to 
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US$2,000 per day.[32] Although a relatively small percentage 
(6%) of ventilated patients experience prolonged MV, these pa-
tients consume 37% of ICU resources.[33] Additionally, failure 
to extubate is associated with high mortality and morbidity by 
inducing deleterious effects such as aspiration, atelectasis, and 
pneumonia.[34] 
Patients undergoing lung transplantation should be cautiously 
weaned from MV in a timely manner. Most lung transplantation 
patients are physically debilitated because transplantation tends 
to be the last treatment option in end-stage lung disease. They 
usually suffer from long-term malnutrition and sarcopenia, lack 
of physical activity due to oxygenation failure, and cardiac co-
morbidities such as right heart failure. 
In the literature, a limited number of predictors for ventilator 
weaning or extubation failure have been suggested.[11-13] One 
study reported that the immediate postoperative PaO2 to FiO2 ra-
tio, a history of preexisting pulmonary hypertension, and the 
pulmonary blood flow distribution were good predictors of the 
ICU length of stay following single lung transplantation.[10] In 
addition to these predictors, our study suggests that preoperative 
BMI and larger TVs before the SBT may be reasonable pre-
dictors of weaning in lung transplantation patients. In previous 
literature, TV was not commonly highlighted as a predictor of 
delayed weaning or weaning failure. However, RSBI, which 
was noticed because of its high predictive value,[12] showed 
some trends, but the small study population may explain why 
RSBI failed to be a significant predictor of weaning success. 
Because the RR was similar between the two groups during the 
SBTs, RSBI was not statistically significant. The patients with 
end-stage lung disease had long-term exposure to hypoxia and 
hypercapnia, so their respiratory drive was decreased. Also, 
their postoperative pain was controlled with high-dose opioids, 
specifically remifentanil via intravenous infusion, which may 
contribute to the patients breathing more deeply and slowly after 
lung transplantation.
In this study, older age was associated with early weaning. 
When we compared the younger age group (< 53 years) to the 
older group, the younger group also had a lower BMI. One 
thought is that end-stage lung disease rapidly wastes the meta-
bolic reserve in younger patients. Total energy expenditure, 
which includes resting energy expenditure, is known to decrease 
with the aging process.[35] Therefore, it is possible that elderly 
patients are more resistant to malnutrition because weight-ad-
justed energy expenditure is lower in the elderly.[36] 
Prolonged MV is associated with VAP. As demonstrated in 
COPD patients, higher BMIs could be associated with early 
weaning from MV,[21] possibly due to improved immunity. 
Therefore, the relationship between BMI and VAP warrants fur-
ther investigation.
Compared to other studies, the duration of MV in this study 
was longer, while weaning failure after the first successful SBT 
occurred in only two patients. These results suggest that there is 
room for a faster weaning process in our practice. In addition, 
the limited number of cases in this study requires further analy-
sis of the variables we chose to study. The small number of the 
patients in this study (n = 17) is one reason why the predictive 
power was not analyzed by a receiver operating characteristic 
curve.
In the present study, we demonstrated MV more than 8 days 
after unilateral or bilateral lung transplantation to be associated 
with lower BMI and smaller tidal volume before SBT. Notably, 
postoperative comorbidities associated with prolonged MV 
were found to be ECMO use and VAP. 
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